Active Ingredient: DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
Proprietary Name: VIEKIRA XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N208624
Product Number: 001
Approval Date: Jul 22, 2016
Applicant Holder Full Name: ABBVIE INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
